ArticleCase reports in neurological medicine2026
A 14-Year-Old Male With Susac Syndrome: A Case Report.
Article in Case reports in neurological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A 14-Year-Old Male With Susac Syndrome: A Case Report.Case reports in neurological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Importance: Susac syndrome (SuS) is a rare autoimmune microangiopathy involving the brain, retina, and inner ear. It is uncommon in children, and early diagnosis is essential to prevent irreversible deficits. Case Presentation: A 14-year-old boy presented with decreased consciousness following 18 days of excessive sleepiness, vomiting, blurred vision, and unsteady gait. There was no family history of autoimmune diseases. MRI showed "snowball-like" corpus callosum lesions suggestive of SuS. Cerebrospinal fluid (CSF) revealed lymphocytic pleocytosis and elevated protein. He improved partially with intravenous methylprednisolone but later developed status epilepticus, requiring plasma exchange. During steroid taper, he experienced relapses with visual and gait disturbances. Fluorescein angiography (FA) confirmed branch retinal artery occlusions (BRAOs). Immunosuppressive therapy with azathioprine and rituximab was initiated, achieving disease stability. Clinical Discussion: MRI findings of corpus callosum "snowball" lesions are a key clue for early diagnosis. Multimodal management-including corticosteroids, plasma exchange, and long-term immunosuppression-is essential to control relapses and prevent permanent sequelae. The patient's fluctuating course underscores the need for ongoing monitoring. Conclusion: The identification of snowball lesions in the corpus callosum, in conjunction with a "string of pearls" appearance in the internal capsule, mandates prompt immunotherapeutic intervention. Rituximab is currently regarded as the preferred agent, given that azathioprine has demonstrated limited efficacy in moderating disease activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.